Sun Life Financial (TSE:SLF) PT Lowered to C$78.00 at Jefferies Financial Group

Sun Life Financial (TSE:SLF) (NYSE:SLF) had its price objective trimmed by Jefferies Financial Group from C$83.00 to C$78.00 in a research note published on Thursday morning, BayStreet.CA reports.

A number of other analysts have also recently issued reports on the company. Royal Bank of Canada decreased their target price on Sun Life Financial from C$77.00 to C$76.00 and set an outperform rating for the company in a research report on Monday, May 13th. National Bankshares decreased their target price on Sun Life Financial from C$73.00 to C$72.00 in a research report on Friday, May 10th. BMO Capital Markets decreased their target price on Sun Life Financial from C$80.00 to C$79.00 and set an outperform rating for the company in a research report on Monday, May 13th. TD Securities upped their target price on Sun Life Financial from C$71.00 to C$73.00 in a research report on Friday, July 12th. Finally, Scotiabank decreased their target price on Sun Life Financial from C$76.00 to C$73.00 and set an outperform rating for the company in a research report on Monday, May 13th. Two equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of Moderate Buy and a consensus target price of C$75.73.

Sun Life Financial Trading Down 0.8 %

TSE:SLF opened at C$68.00 on Thursday. The stock has a 50-day simple moving average of C$67.86 and a 200-day simple moving average of C$70.13. The stock has a market cap of C$39.52 billion, a P/E ratio of 13.08, a P/E/G ratio of 1.25 and a beta of 0.96. Sun Life Financial has a 1 year low of C$61.84 and a 1 year high of C$74.94. The company has a debt-to-equity ratio of 26.46, a quick ratio of 84,866.00 and a current ratio of 56.69.

Sun Life Financial (TSE:SLF) (NYSE:SLF) last released its quarterly earnings data on Thursday, May 9th. The financial services provider reported C$1.50 earnings per share (EPS) for the quarter, missing the consensus estimate of C$1.64 by C($0.14). The business had revenue of C$6.88 billion for the quarter, compared to analyst estimates of C$9.96 billion. Sun Life Financial had a return on equity of 13.68% and a net margin of 10.12%. As a group, analysts anticipate that Sun Life Financial will post 6.3499079 earnings per share for the current fiscal year.

Sun Life Financial Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, June 28th. Shareholders of record on Wednesday, May 29th were paid a dividend of $0.81 per share. The ex-dividend date of this dividend was Wednesday, May 29th. This is an increase from Sun Life Financial’s previous quarterly dividend of $0.78. This represents a $3.24 annualized dividend and a yield of 4.76%. Sun Life Financial’s dividend payout ratio is currently 62.31%.

Insider Buying and Selling at Sun Life Financial

In other Sun Life Financial news, Director Kevin Strain bought 12,000 shares of the business’s stock in a transaction dated Tuesday, June 4th. The stock was acquired at an average cost of C$67.48 per share, with a total value of C$809,760.00. In other Sun Life Financial news, Director Kevin Strain bought 12,000 shares of the business’s stock in a transaction dated Tuesday, June 4th. The stock was acquired at an average cost of C$67.48 per share, with a total value of C$809,760.00. Also, Director Stephanie Coyles bought 900 shares of the business’s stock in a transaction dated Tuesday, May 14th. The shares were acquired at an average cost of C$69.15 per share, with a total value of C$62,235.00. 0.03% of the stock is owned by company insiders.

About Sun Life Financial

Sun Life Financial Inc, a financial services company, provides savings, retirement, and pension products worldwide. The company operates in five segments: Asset Management, Canada, U.S., Asia, and Corporate. It offers various insurance products, such as term and permanent life; personal health, which includes prescription drugs, dental, and vision care; critical illness; long-term care; and disability, as well as reinsurance.